Autor: Antonio Berlen

joimax® Rolls Out Its Endoscopic Generation 4 Devices and Showcases New 3D-Printed Titanium Implants at the German Spine Society (DWG) Convention

Veröffentlicht am von Antonio Berlen

Karlsruhe (GER) / Irvine, CA – December 6, 2018 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is well positioned for Germany’s principal spine convention, German Spine Society (DWG), taking place December 6 to 8 in Wiesbaden, Germany.

Joimax, Endoscopic spine surgery, Minimally invasive, Transforaminal, Interlaminar, Training and Education, EndoLIF Implants, Navigation, Generation4, next Generation, tower, endoscopic

This year, joimax® is focusing on their Endoscopic Tower Generation 4 Devices, an expert solution for spinal surgery. They will showcase the new Camsource® LED, a fully integrated camera and light source system that delivers brilliant images up to 4K; and the Vitegra®, the integrated visualization, documentation and commanding device. This marks the global launch of both devices, including in Europe, Asia, and the United States.

Moreover, joimax® will exhibit its EndoLIF® product line: the well-known 3D-printed EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the EndoLIF® Double Wedge Cage (approval expected shortly).

“The main advantage of the EndoLIF® Implants is the gentle and atraumatic access via gradual tissue dilatation — muscles remain intact and infection risk is reduced. Using 3D-printing technology, an open diamond cell structure, and a rough and porous surface, leads to optimal bone ingrowth, stability and finally fusion,” states Wolfgang Ries, Founder and CEO of the joimax® Group. “Even awake, fusion with very fast patient recovery has started to be realized on the base of endoscopic minimally-invasive techniques.”

Additionally, joimax®  will show Intracs® em, the first complete electromagnetic navigation system for endoscopic minimally invasive spine surgery. Intracs® is an easy to set up, user-friendly system that can serve as a stand-alone device. It relies on electromagnetic tracking and was designed specifically for simple and safe access to any spinal target. It’s the only device on the market that allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes, also developed by joimax®.

Besides an expanded booth presence with daily Meet-the-Expert Sessions, joimax® will again host two lunch symposiums on endoscopic spinal procedures: one covering endoscopic pain therapy, and the other addressing diverse intracanal surgical treatment modalities, including endoscopic fusion.

joimax® at CAOS in Beijing, China

Veröffentlicht am von Antonio Berlen

The 8th Annual Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) was held at the Beijing International Convention Center, Beijing, China on May 7-10.

joimax® joined this important international event both as an exhibitor and as an education partner. CAOS, in collaboration with NASS, created the “Techniques in Complex Spine Surgery” program which featured six 1-hour live technique demonstrations, two 3-hour hands-on cadaver workshops, and five lectures with discussion. As expert support for this exciting program, CAOS invited two members of the joimax® Faculty Team: Dr. Guntram Krzok, Friedrichroda, Germany and Dr. Ralf Wagner, Frankfurt, Germany.
The two surgeons delivered well-visited lectures and demonstrated the joimax® TESSYS® technique. As a highlight of the event, the technique demonstrations were shared via webcast and more than 1000 surgeons viewed the program in the Beijing convention hall. More than 26,000 surgeons, surgical nurses and technicians viewed the demos online which enabled maximum visibility for joimax and its technologies.

The joimax® team members who supported the event on-site were deeply impressed by the strong interest in the latest spine surgery systems coming from many Chinese surgeons. Needless to say China is the largest medical market in the world and joimax® will continue to strengthen its relationship with local partners and training centers.

Live webcast during joimax® TESSYS® technique demonstration at CAOS 2015.

joimax® moves into larger premises

Veröffentlicht am von Antonio Berlen

joimax® invests in the future and moves into new offices in the US and in Germany

Irvine, USA / Karlsruhe, Germany – 14. Juni 2010 – The medical devices company
joimax® GmbH is moving into new premises both in Germany and the US. „Growth requires space“ had already been the motto of the last company move back in 2005.
The US market has an enormous growth potential. This is why the subsidiary joimax® Inc. is moving from Campbell to Irvine, California, one of high-tech industry centers in the United States. To meet the growing requirements of the US market the joimax® headquarter in Karlsruhe, Germany is also moving into bigger offices. President and founder Wolfgang Ries states: “This step of expansion was necessary to comply with the growing requirements towards our organisation.” “The new premises are a perfect operational basis to be able to cover the growing demand for joimax technologies in the US“, explains Chip Stevens, CEO of joimax Inc.

The doubling of the operational areas is also a landmark decision with respect to the ongoing product launches of the company. joimax® is preparing the launch of the Shrill® in Europe which will shortly be followed by the US launch. This shaver and drill system for the ablation of bone and soft tissue under endoscopic view will be completed by a new pump system called Versicon® and an HD endoscopy system. Following the motto „joimax goes HD“ the so-called Camsource® HD Twister camera system, new HD flat screen monitors and HD endoscopes will be brought to market.

Veröffentlicht in 2010

joimax® Launches NAVENTO® Navigation Endoscopic Tower at NASS and EUROSPINE

Veröffentlicht am von Antonio Berlen

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation tower, NAVENTO® Navigation Endoscopic Tower. Optimized for endoscopic spine surgery with special settings for the safe treatment of sensitive structures, NAVENTO® will be featured at the North American Spine Society (NASS) meeting in Boston later this month and at EUROSPINE in Vienna this October.

joimax endoscopic tower NAVENTO

NAVENTO®, the fully integrated fourth generation endo-tower, contains everything a surgeon needs to perform a successful procedure. The tower boasts updated design features for enhanced usability and is composed of six devices that work in unison to give the user the best possible surgical experience:

  1. Vitegra®, the brain of NAVENTO®, offers complete documentation and data management.
  2. Camsource® LED provides optimal clarity up to 4K resolution.
  3. Intracs®, the newest device from joimax®, delivers electromagnetic navigation at the instrument’s tip.
  4. Shrill®, the shaver drill system, with the newest generation recently launched, provides optimal RPMs and torque management.
  5. Endovapor® 2 poses electrosurgical offerings for monopolar and bipolar settings.
  6. Versicon®, delivers fluid and pressure regulation.

“joimax® continues to lead the endoscopic spine market through innovations in technologies aimed to increase the user experience and provide spinal patients with an ultra-minimally invasive treatment option,” stated Christoph Hofstetter, M.D., Ph.D., associate professor in the Department of Neurological Surgery at the University of Washington.

Wolfgang Ries, CEO and founder of the joimax® group, confirmed, “NAVENTO® pulls together the latest technologies forming one complete, seamlessly integrated spinal endoscopic package.”

NAVENTO®, along with the full suite of joimax® endoscopic technologies will be showcased at NASS, booth #3512, and at EUROSPINE, booth #04.

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Veröffentlicht am von Antonio Berlen

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.

During the AANS, joimax®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

joimax RF Generator Endovapor 2

joimax® celebrates 10 successful years on the market with TESSYS® at the WCMISST in Paris

Veröffentlicht am von Antonio Berlen

Karlsruhe, 11.06.2014. joimax® looks back on 10 years of success with the surgical application of TESSYS® for the minimally invasive, endoscopic removal of herniated discs; a particularly gentle surgical technique which utilizes the natural transforaminal access to the spinal canal. TESSYS® was the first product that brought joimax® to market and was a breakthrough for the company. Today, joimax® offers a highly diversified product portfolio for 360° surgery in almost all areas of the spine including endoscopic and percutaneous stabilization.

During the award ceremony in Paris, two TESSYS® pioneers will be awarded with the “Parviz Kambin Honorary Award”: Dr. Florian Maria Alfen of Würzburg, who bought the very first TESSYS® system in 2004 and has successfully operated on more than 2,500 patients. As a member of the joimax® Faculty Team, Dr. Alfen has trained a large number of surgeons. The second award winner is Dr. Daniel Laich of Chicago. He is the very first TESSYS® user in the U.S. and has been a faculty member since 2009. Since 2013, he has also been operating as a scientific advisor for the company.

Since 2004, more than 100,000 patients in 30 countries were surgically treated with the TESSYS® method and its subsequent surgical developments. Follow-up studies show a significantly shorter recovery time, faster return to work and normal activities with improved quality of life and ultimately, lower costs to the social system.

At the WCMISST, the 4th World Congress of Minimally Invasive Spine Surgery and Techniques, joimax® presents its latest development- the EndoLIF® system for endoscopic stabilization of the lumbar spine. Aside from fully endoscopic access via the proven TESSYS® and iLESSYS® methods, the EndoLIF® system contains an O-Cage for oblique interbody fusion. In addition, joimax® presents its new Percusys® System- a posterior, percutaneous screw and rod system. The advantages of these products and procedures are apparent:

– Smooth, atraumatic access due to gentle dilation of tissue
– Dura and nerves are protected by the working tubes
– Dorsal bone structures are generally not affected and remain intact
– O-Cage with an osteo-conductive surface provides the optimum substrate for cellular growth
– Posterior, percutaneous stabilization via the minimally invasive screw and rod system

Both of these systems are CE marked and FDA clearance is in progress.

Visit us at WCMISST, booth #15 at the Marriott Rive Gauche Hotel and discover for yourself the many advantages of our newest systems.

Collage_WC_MISST_Paris_2014_med

Champions of Health Interview with
Mr. Wolfgang Ries – CEO and Founder of joimax®

Veröffentlicht am von Antonio Berlen

Champions of Health: Spotlight On Leaders Shaping Germany’s Healthcare

We are delighted to inform that an interview with the CEO and Founder of joimax®, Mr. Wolfgang Ries, has been published in the Champions of Health magazine.

The Interview

In this insightful interview, Mr. Ries shares the inspiring story behind the founding of joimax® and provides an in-depth look at our cutting-edge products and innovations that are shaping the future of minimally invasive endoscopic spine surgery. 

I believe in fostering a culture of collaboration and teamwork as well as empowerment within the organization. By encouraging open communication and valueing diverse perspectives, I ensure that decisions are well-informed and reflective of the collective wisdom of the team.

Mr. Wolfgang Ries
CEO and Founder of joimax® 

This publication serves as an opportunity to showcase the dedication of joimax® to advancing endoscopic minimally invasive spine spine surgery technology and improving patient care.

Read more

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Veröffentlicht am von Antonio Berlen

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

CMS Includes Endoscopic Spine in Fee Schedule Proposed Rule for CY 2017

Veröffentlicht am von Antonio Berlen

Baltimore, MD – July 14, 2016– The Centers for Medicare & Medicaid Services (CMS) recently released the proposed rules for the 2017 Medicare Physician Fee Schedule (MPFS) and the 2017 Hospital Outpatient Prospective Payment System (HOPPS). Both proposed rules provide information on physician and hospital payment for the newly created CPT code 630X1 for endoscopic decompression of the lumbar spine.

“This is a great step towards the acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the surgeon and their patients in the U.S.,” said Wolfgang Ries, Founder and CEO of joimax®. This announcement is in alignment with the reimbursement decision of NICE, UK, in April of 2016, to fully reimburse endoscopic procedures.

A key reason for the recent momentum for endoscopic, minimally invasive spinal surgery is the significant, favorable base of literature, which validates evidence of the efficacy of endoscopic minimally invasive spine surgery. A special edition, “Neurosurgical Focus”, published by the Journal of Neurosurgery (JNS) in February 2016, contains a range of studies on endoscopic spine surgery.

The Society for Minimally Invasive Spine Surgery Announces Agreement With joimax® To Support Creation and Launch of SMISS Registry for Endoscopic Spine Surgery

Veröffentlicht am von Antonio Berlen

San Diego, Oct. 20, 2011 – The Society for Minimally Invasive Spine Surgery (SMISS), San Diego, CA and joimax®, Karlsruhe, Germany announced today the signing of an agreement to support the SMISS Registry as a founding sponsor for creation and launch of the SMISS Spine Registry for Minimally Invasive Endoscopic Spine Surgery. The SMISS Spine Registry was designed to collect valuable data concerning decreased hospitalization, recovery times, and complication rates of endoscopic spine procedures, as well as increased quality of life measures, subject satisfaction, and cost effectiveness. In today’s rapidly changing healthcare climate, it is imperative to ensure the ongoing availability of this data regarding efficiencies of care and quality of outcomes.

SMISS has assembled an outstanding research team with extensive experience within the spine field. The Principal Investigator for the Registry, Choll Kim, M. D., Ph.D, Executive Director and Board of Directors Member of SMISS states, “We are excited to partner with joimax® in the launch of the SMISS Registry, a project that will produce the relevant data collection and management necessary for the continued growth of minimally invasive endoscopic spine surgery. The Society will lead the way in the collection of minimally invasive spine surgery outcomes and cost data. SMISS is positioned to become the model for successful spine research.”

“joimax® and SMISS are ideal partners to begin this important project in spinal endoscopy. The data collected will assist both parties in furthering the development of minimally invasive endoscopic spinal surgery, which is a great benefit to patients around the world,” said Wolfgang Ries, CEO and Founder of joimax. “We are pleased to provide funding for this important project.”

This three year, multi-centered project will commence patient enrollment in late 2011. The Registry is expected to enroll a minimum of 250 patients during the first phase of the project.